Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,726 | -6,087 | -1,067 | -56,204 | -33,991 |
| Accounts payable and accrued liabilities | 2,807 | 2,102 | 2,814 | -2,668 | -2,035 |
| Other Working Capital | 3,841 | 3,183 | 368 | -229 | -357 |
| Other Operating Activity | -1,531 | -9,605 | -9,148 | 19,134 | 5,781 |
| Operating Cash Flow | $-13,609 | $-10,408 | $-7,033 | $-39,967 | $-30,602 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,491 | 8,651 | 4,415 | 17,344 | 8,580 |
| Financing Cash Flow | $20,491 | $8,651 | $4,415 | $17,344 | $8,580 |
| Beginning Cash Position | 5,755 | 5,755 | 5,755 | 28,378 | 28,378 |
| End Cash Position | 12,637 | 3,998 | 3,137 | 5,755 | 6,355 |
| Net Cash Flow | $6,882 | $-1,757 | $-2,618 | $-22,623 | $-22,023 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,609 | -10,408 | -7,033 | -39,967 | -30,602 |
| Free Cash Flow | -13,609 | -10,408 | -7,033 | -39,967 | -30,602 |